[1] Domingo, P., Estrada, V., Lopez-Aldeguer, J., et al. (2012) Fat Redistribution Syndromes Associated with HIV-1 Infection and Combination Antiretroviral Therapy. AIDS Reviews, 14, 112-123.
[2] James, J., Carruthers, A. and Carruthers, J. (2002) HIV-Associated Facial Lipoatrophy. Dermatologic Surgery, 28, 979-986.
[3] Collins, E., Wagner, C. and Walmsley, S. (2000) Psychosocial Impact of the Lipodystrophy Syndrome in HIV Infection. AIDS Reader, 10, 546-551.
[4] Bergeret-Galley, C. (2004) Comparison of Resorbable Soft Tissue Fillers. Aesthetic Surgery Journal, 24, 33-43.
http://dx.doi.org/10.1016/j.asj.2004.01.006
[5] Larsen, N.E., Pollak, C.T., Reiner, K., et al. (1993) Hylan Gel Biomaterial: Dermal and Immunologic Compatibility. Journal of Biomedical Material Research, 27, 1129-1134.
http://dx.doi.org/10.1002/jbm.820270903
[6] Bes, G. (2003) Efficacite du Juvederm 30: un an de suivi. Réalités thérapeutiques en Dermato-Vénérologie, 127, 45-49.
[7] Tzikas, T. (2004) Evaluation of the Radiance FN Soft Tissue Filler for Facial Soft Tissue Augmentation. Archive of Facial Plastic Surgery, 6, 234-239.
http://dx.doi.org/10.1001/archfaci.6.4.234
[8] Pettit, D.K., Lawter, J.R., Huang, W.J., et al. (1997) Characteri-zation of Poly(glycoide-co-D, L-lactide)/Poly(D, L-lactide) Microspheres for Controlled Release of GM-CSF. Pharmaceutical Research, 14, 1422-1430.
http://dx.doi.org/10.1023/A:1012176823155
[9] Mole, B. (1992) The Use of Gore-Tex Implants in Aesthetic Surgery of the Face. Plastic Reconstructive Surgery, 90, 200-206.
http://dx.doi.org/10.1097/00006534-199290020-00007